These Penny Stocks Are Seeing Big Action At The End Of The Week
Trading penny stocks can be extremely profitable if done correctly. This is thanks to penny stock volatility and additional catalysts like news. Company announcements are a very big deal for penny stocks because they can lead to a surge of volume. Obviously this can be buying or selling volume but good penny stock news can trigger big moves.
However, penny stock traders must also be wary of this volatility. This can quickly turn against investors and result in heavy losses. This is why you should always trade with a game plan that uses things like stop-losses in case a trade turns sour.
You should also do proper research on any penny stock you look to put money into. Blindly following hype or trying to time volatility without a plan usually ends in more losses than gains. With all of this in mind, here are some penny stocks to watch on October 25th:
Penny Stocks To Trade: Aclaris Therapeutics Inc. (ACRS)
Kicking things off this morning is Aclaris Therapeutics Inc. (ACRS Stock Report). Aclaris Therapeutics is a biotechnology company primarily focused on identifying and developing novel medicines for skin and hair disorders. The company has over 10 potential product candidates in its clinical pipeline.
Aclaris’ stock has been thriving in October; it is up over 55% this month. On October 25th, the biotech penny stock gapped up 12% during premarket hours thanks to some news.
The company announced that its A-101 Topical Solution met its primary and secondary efficacy endpoints in its Phase 3 trial. These statistics support A-101’s viability as a treatment for warts.
[Read More]
- 5 Penny Stocks To Buy Or Sell After October News
- Top Penny Stocks To Add To Your Watch List Before November?
- 3 Penny Stocks Making Big Moves This Week; 1 Over 200%
“These results provide robust clinical evidence for the efficacy and safety of A-101 45% and support its viability as a potential treatment for common warts. These data will serve as the basis for an NDA filing, and we believe A-101 45% will be of interest to partners seeking to commercialize this drug candidate, which has the potential to be the first FDA -approved prescription treatment for common warts.”
Dr. David Gordon , Chief Medical Officer of Aclaris
Penny Stocks To Trade: Actinium Pharmaceuticals Inc. (ATNM)
The next biopharmaceutical company has a slightly different focus. Actinium Pharmaceuticals Inc. (ATNM Stock Report) is a biotechnology company that is developing Antibody Radiation-Conjugates which selectively kill patient’s cancer cells. The company’s lead product candidate is called Iomab-B is in its phase 3 trial for Acute Myeloid Leukemia.
The company was on fire during the trading session on October 24th. The penny stock had a heavy gap down on August 18th and has not been able to recover until the 24th.
The stock price rose 42% while having its largest trading volume in 52-weeks. Actinium’s stock is looking for continuation during October 25th’s trading session and is already gapping up 6% in premarket hours.
Penny Stocks To Trade: Chesapeake Energy Corporation (CHK)
The final company on this list takes us away from the healthcare sector and into the energy sector. Chesapeake Energy Corporation (CHK Stock Report) is an energy company that acquires and develops oil, natural gas, and natural gas liquid properties. In addition to these properties, the company produces 521,000 barrels of oil per day.
This week has been extremely fruitful for Chesapeake Energy’s stock. Since Monday, October 21st, the stock has risen from $1.283 all the way to $1.47 on Thursday. This 16.5% move came after the company announced some penny stock news.
Chesapeake revealed that the company will have its Q3 earnings call on November 5th. The company also declared dividends for its preferred stockholders.
